日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-world efficacy and toxicity of ipilimumab and nivolumab as a first-line treatment for advanced renal cell carcinoma according to IMDC risk criteria-A multi-center retrospective analysis on behalf of the GUARDIANS group

根据IMDC风险标准，评估伊匹木单抗和纳武利尤单抗作为晚期肾细胞癌一线治疗的真实世界疗效和毒性——GUARDIANS研究组开展的一项多中心回顾性分析

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.70267
Dinkel, Hendrik; Materna, Linus; Stelmach, Ramona; Zschäbitz, Stefanie; Neuberger, Stephanie; Aydogdu, Can D; Casuscelli, Jozefina; Egenolf, Timo; Silberg, Matteo; Steinestel, Julie; Strauss, Arne; Kirchhoff, Florian; Ahrens, Marit; Paffenholz, Pia; Cathomas, Richard; Özdemir, Berna C; Gossler, Christopher; Ivanyi, Philipp; Rehlinghaus, Marc; Hilser, Thomas; Grünwald, Viktor; Schlack, Katrin
肿瘤
MDC
肿瘤免疫
肾癌
细胞生物学
毒理研究
发表日期：2026
文献求助 收藏

Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project

一项回顾性多中心分析提供的真实世界证据：转移性乳头状肾细胞癌一线治疗。GUARDIANS 项目

期刊:European Urology Open Science
影响因子:4.5
doi:10.1016/j.euros.2025.06.011
Hilser, Thomas; Casuscelli, Jozefina; Aydogdu, Can; Zschäbitz, Stefanie; Schnabel, Marco Julius; Rinderknecht, Emily; Mattigk, Angelika; Schostak, Martin; Volk, Anna-Lisa; Ivanyi, Philipp; Wiegmann, Jonas; Darr, Christopher; Flegar, Luka; Mandal, Subhajit; Schlack, Katrin; Seidl, Daniel; Handke, Analena; Klee, Melanie; Nestler, Tim; Rehlinghaus, Marc; Hijazi, Sameh; Heidenreich, Axel; Grünwald, Viktor; Paffenholz, Pia
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy.

TROP-2 在乳头状肾细胞癌中的过度表达支持其作为抗体药物偶联疗法的治疗靶点的潜力

期刊:World Journal of Urology
影响因子:2.9
doi:10.1007/s00345-025-05880-2
Kessler Carolina, von Brandenstein Melanie, Klümper Niklas, Krausewitz Philipp, Storz Enno, Rieger Constantin, Sperber Laurenz, Paffenholz Pia, Tolkach Yuri, Wirtz Ralph, Eckstein Markus, Heidenreich Axel, Weiten Richard
细胞生物学
发表日期：2025
文献求助 收藏

Expression and therapeutic potential of TROP2 in cisplatin-resistant germ cell tumors.

TROP2 在顺铂耐药性生殖细胞肿瘤中的表达和治疗潜力。

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06325-4
Sperber Laurenz, von Brandenstein Melanie, Kessler Carolina, Heidenreich Julian, Storz Enno, Pfister David, Paffenholz Pia, Tolkach Yuri, Bernhardt Marit, Wirtz Ralph, Eckstein Markus, Heidenreich Axel, Weiten Richard
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

[Next generation sequencing (NGS)-based molecular panel analysis for metastatic prostate cancer: how often can we detect druggable mutations? : NGS for metastatic adenocarcinoma of the prostate]

[基于下一代测序 (NGS) 的转移性前列腺癌分子panel分析：我们能检测到多少次可药物靶向突变？：前列腺转移性腺癌的NGS]

期刊:
影响因子:
doi:10.1007/s00120-024-02493-2
Steenbock, Olivia; Paffenholz, Pia; Rieger, Constantin; Heidenreich, Julian; Pfister, David; von Brandenstein, Melanie; Heidenreich, Axel
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study

在DRKS-00019223研究中，通过血清microRNA-371a-3p水平检测I期睾丸生殖细胞肿瘤的复发

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-0730
Belge, Gazanfer; Dumlupinar, Cansu; Nestler, Tim; Klemke, Markus; Törzsök, Peter; Trenti, Emanuela; Pichler, Renate; Loidl, Wolfgang; Che, Yue; Hiester, Andreas; Matthies, Cord; Pichler, Martin; Paffenholz, Pia; Kluth, Luis; Wenzel, Mike; Sommer, Jörg; Heinzelbecker, Julia; Schriefer, Philipp; Winter, Alexander; Zengerling, Friedemann; Kramer, Mario Wolfgang; Lengert, Marie; Frey, Jana; Heidenreich, Axel; Wülfing, Christian; Radtke, Arlo; Dieckmann, Klaus-Peter
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Medical care services provision and stress experience in urologists during all waves of the COVID-19 pandemic in Germany

德国泌尿科医生在新冠疫情各波次期间的医疗服务提供情况及压力体验

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2024.1320489
Paffenholz, Pia; Platen, Moritz; Kostev, Karel; Loosen, Sven H; Bohlken, Jens; Michalowsky, Bernhard
微生物学
新冠
发表日期：2024
文献求助 收藏

Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort

Enfortumab Vedotin治疗转移性尿路上皮癌：一项欧洲多中心真实世界患者队列研究的生存率和安全性

期刊:European Urology Open Science
影响因子:4.5
doi:10.1016/j.euros.2023.04.018
Zschäbitz, Stefanie; Biernath, Nadine; Hilser, Thomas; Höllein, Alexander; Zengerling, Friedemann; Cascucelli, Jozefina; Paffenholz, Pia; Seidl, Daniel; Lutz, Christoph; Schlack, Katrin; Kingreen, Dorothea; Klümper, Niklas; Ivanyi, Philipp; von Amsberg, Gunhild; Heers, Hendrik; Roghmann, Florian; Tauber, Robert L; Cathomas, Richard; Hofer, Luisa; Niegisch, Günter; Klee, Melanie; Ehrenberg, Roland; Hassler, Andreas; Hadaschik, Boris A; Grünwald, Viktor; Darr, Christopher
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment

肿瘤标志物水平误用会导致国际生殖细胞共识分类（IGCCCG）风险分组不准确，并影响治疗效果。

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.6304
Majewski, Matthäus; Paffenholz, Pia; Ruf, Christian; Che, Yue; Seidel, Christoph; Heinzelbecker, Julia; Schmelz, Hans-Ulrich; Matthies, Cord; Albers, Peter; Bokemeyer, Carsten; Heidenreich, Axel; Pichler, Martin; Nestler, Tim
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

German specialists treating testicular cancer follow different guidelines with resulting inconsistency in assessment of retroperitoneal lymph-node metastasis: clinical implications and possible corrective measures

德国治疗睾丸癌的专家遵循不同的指南，导致对腹膜后淋巴结转移的评估不一致：临床意义及可能的纠正措施

期刊:World Journal of Urology
影响因子:2.9
doi:10.1007/s00345-023-04364-5
Schoch, Justine; Haunschild, Kathrin; Strauch, Angelina; Nestler, Kai; Schmelz, Hans; Paffenholz, Pia; Pfister, David; Persigehl, Thorsten; Heidenreich, Axel; Nestler, Tim
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏